Medtronic FDA Approval Marks a Turnaround in the Paclitaxel Story

Medtronic FDA Approval Marks a Turnaround in the Paclitaxel Story

Submitted by admin on November 22, 2019 - 10:19am
Source: 
Medical Devices and Diagnostics Industry
News Tags: 
Medtronic
devices
IN.PACT
drug-coated balloons
renal disease
Headline: 
Medtronic FDA Approval Marks a Turnaround in the Paclitaxel Story
snippet: 

FDA approved Medtronic's IN.PACT AV drug-coated balloon for the treatment of failing arteriovenous access in patients with end-stage renal disease undergoing dialysis.

Do Not Allow Advertisers to Use My Personal information